Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Raymond James reports October clients assets under administration up 33% » 16:36
11/23/21
11/23
16:36
11/23/21
16:36
RJF

Raymond James

$100.74 /

+2.095 (+2.12%)

Raymond James Financial…

Raymond James Financial reported selected operating data for October, in an effort to provide timely information to investors about general trends in our major business segments. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed. Record client assets under administration of $1.23T increased 33% over October 2020 and 4% over September. Record financial assets under management of $199.3B increased 32% over October 2020 and 4% over September. The increase of client assets was driven by equity market appreciation and the net addition of financial advisors in the Private Client Group. Record net loans at Raymond James Bank of $25.4B increased 18% over October 2020 and 2% over September. Record clients' domestic cash sweep balances of $66.8B increased 17% over October 2020 and were flat compared to September.

ShowHide Related Items >><<
RJF Raymond James
$100.74 /

+2.095 (+2.12%)

RJF Raymond James
$100.74 /

+2.095 (+2.12%)

10/22/21 B. Riley
TriState Capital downgraded to Neutral on takeover at B. Riley
10/21/21 JMP Securities
Raymond James price target raised to $112 from $103 at JMP Securities
10/11/21 Citi
Raymond James added to U.S. Focus List at Citi
09/17/21 Citi
Citi ups Raymond James target, opens 'Positive Catalyst Watch'
RJF Raymond James
$100.74 /

+2.095 (+2.12%)

RJF Raymond James
$100.74 /

+2.095 (+2.12%)

RJF Raymond James
$100.74 /

+2.095 (+2.12%)

Over a month ago
Earnings
Raymond James reports Q4 EPS $2.06, consensus $1.71 » 16:44
10/27/21
10/27
16:44
10/27/21
16:44
RJF

Raymond James

$99.96 /

-2.445 (-2.39%)

Reports Q4 revenue $2.7B,…

Reports Q4 revenue $2.7B, consensus $2.54B. Reports quarter-end records for client assets under administration of $1.18 trillion, financial assets under management of $191.9B, and net loans at Raymond James Bank of $25B. "In fiscal 2021, we've proven once again that focusing on our time-tested client-first strategy of providing outstanding service to our advisors and their clients will guide us through uncertain market, economic and global conditions, in this case in record-setting fashion," said Chairman and CEO Paul Reilly. "Through a combination of diverse and complementary businesses, we generated record results for the firm in fiscal 2021, which included record net revenues and pre-tax income in the Private Client Group, Capital Markets and Asset Management segments. We are well positioned entering fiscal 2022, with strong capital ratios and quarter-end records for client assets, the number of Private Client Group financial advisors and net loans at Raymond James Bank. Furthermore, financial advisor recruiting activity remains robust across all of our affiliation options and our investment banking pipelines are strong."

ShowHide Related Items >><<
RJF Raymond James
$99.96 /

-2.445 (-2.39%)

RJF Raymond James
$99.96 /

-2.445 (-2.39%)

10/22/21 B. Riley
TriState Capital downgraded to Neutral on takeover at B. Riley
10/21/21 JMP Securities
Raymond James price target raised to $112 from $103 at JMP Securities
10/11/21 Citi
Raymond James added to U.S. Focus List at Citi
09/17/21 Citi
Citi ups Raymond James target, opens 'Positive Catalyst Watch'
RJF Raymond James
$99.96 /

-2.445 (-2.39%)

RJF Raymond James
$99.96 /

-2.445 (-2.39%)

RJF Raymond James
$99.96 /

-2.445 (-2.39%)

Downgrade
TriState Capital downgraded to Neutral on takeover at B. Riley » 07:22
10/22/21
10/22
07:22
10/22/21
07:22
TSC

TriState Capital

$31.03 /

+8.295 (+36.49%)

, RJF

Raymond James

$101.73 /

+0.29 (+0.29%)

B. Riley analyst Steve…

B. Riley analyst Steve Moss downgraded TriState Capital (TSC) to Neutral from Buy with a price target of $31, up from $28. The acquisition by Raymond James (RJF) allows TriState to operate as a standalone entity that benefits from lower funding costs and solves its need for low-cost capital due to its strong growth, Moss tells investors in a research note. The analyst views the deal premium as attractive for TriState holders.

ShowHide Related Items >><<
TSC TriState Capital
$31.03 /

+8.295 (+36.49%)

RJF Raymond James
$101.73 /

+0.29 (+0.29%)

TSC TriState Capital
$31.03 /

+8.295 (+36.49%)

10/22/21 B. Riley
TriState Capital downgraded to Neutral from Buy at B. Riley
07/23/21 B. Riley
TriState Capital price target raised to $28 from $26 at B. Riley
07/12/21 B. Riley
TriState Capital upgraded to Buy on share pullback at B. Riley
07/12/21 B. Riley
TriState Capital upgraded to Buy from Neutral at B. Riley
RJF Raymond James
$101.73 /

+0.29 (+0.29%)

10/21/21 JMP Securities
Raymond James price target raised to $112 from $103 at JMP Securities
10/11/21 Citi
Raymond James added to U.S. Focus List at Citi
09/17/21 Citi
Citi ups Raymond James target, opens 'Positive Catalyst Watch'
08/03/21 Citi
Raymond James price target lowered to $205 from $215 at Citi
TSC TriState Capital
$31.03 /

+8.295 (+36.49%)

RJF Raymond James
$101.73 /

+0.29 (+0.29%)

RJF Raymond James
$101.73 /

+0.29 (+0.29%)

TSC TriState Capital
$31.03 /

+8.295 (+36.49%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:32
10/21/21
10/21
12:32
10/21/21
12:32
TSLA

Tesla

$891.70 /

+26.72 (+3.09%)

, T

AT&T

$25.71 /

-0.19 (-0.73%)

, IBM

IBM

$130.07 /

-11.72 (-8.27%)

, PFE

Pfizer

$42.62 /

-0.17 (-0.40%)

, BNTX

BioNTech

$284.51 /

+14.82 (+5.50%)

, DWAC

Digital World Acquisition

$25.69 /

+15.73 (+157.93%)

, DIDI

Didi

$9.56 /

+0.95 (+11.03%)

, AMZN

Amazon.com

$3,427.51 /

+15.19 (+0.45%)

, MU

Micron

$67.90 /

-0.39 (-0.57%)

, FB

Facebook; also tag MVRS

$341.51 /

+0.56 (+0.16%)

, CG

Carlyle Group

$54.71 /

+1.21 (+2.26%)

, TSC

TriState Capital

$30.22 /

+7.49 (+32.95%)

, RJF

Raymond James

$98.68 /

-2.76 (-2.72%)

, KDMN

Kadmon

$9.39 /

+0.81 (+9.45%)

, SNY

Sanofi

$49.07 /

-0.06 (-0.12%)

, SKLZ

Skillz

$9.96 /

+0.79 (+8.62%)

, VALE

Vale

$13.06 /

-0.785 (-5.67%)

, SHPW

Shapeways

$9.07 /

-1.77 (-16.33%)

, AN

AutoNation

$124.42 /

+7.3 (+6.23%)

, CROX

Crocs

$145.75 /

+9.47 (+6.95%)

, EFX

Equifax

$260.66 /

-9.1 (-3.37%)

, FCX

Freeport McMoRan

$37.90 /

-1.03 (-2.65%)

, UNP

Union Pacific

$228.45 /

+0.46 (+0.20%)

, LPSN

LivePerson

$52.30 /

-4.84 (-8.47%)

, PLD

Prologis

$144.21 /

+0.79 (+0.55%)

, DENN

Denny's

$15.46 /

+0.86 (+5.89%)

, TCRR

TCR2 Therapeutics

$6.88 /

-0.295 (-4.11%)

, MTCH

Match Group

$165.86 /

+6.79 (+4.27%)

, GOOGL

Alphabet Class A

$2,823.70 /

-11.32 (-0.40%)

, GOOG

Alphabet

$2,844.15 /

-1.85 (-0.07%)

Get caught up quickly on…

ShowHide Related Items >><<
VALE Vale
$13.06 /

-0.785 (-5.67%)

UNP Union Pacific
$228.45 /

+0.46 (+0.20%)

TSLA Tesla
$891.70 /

+26.72 (+3.09%)

TSC TriState Capital
$30.22 /

+7.49 (+32.95%)

TCRR TCR2 Therapeutics
$6.88 /

-0.295 (-4.11%)

T AT&T
$25.71 /

-0.19 (-0.73%)

SNY Sanofi
$49.07 /

-0.06 (-0.12%)

SKLZ Skillz
$9.96 /

+0.79 (+8.62%)

SHPW Shapeways
$9.07 /

-1.77 (-16.33%)

RJF Raymond James
$98.68 /

-2.76 (-2.72%)

PLD Prologis
$144.21 /

+0.79 (+0.55%)

PFE Pfizer
$42.62 /

-0.17 (-0.40%)

MU Micron
$67.90 /

-0.39 (-0.57%)

MTCH Match Group
$165.86 /

+6.79 (+4.27%)

LPSN LivePerson
$52.30 /

-4.84 (-8.47%)

KDMN Kadmon
$9.39 /

+0.81 (+9.45%)

IBM IBM
$130.07 /

-11.72 (-8.27%)

GOOGL Alphabet Class A
$2,823.70 /

-11.32 (-0.40%)

FCX Freeport McMoRan
$37.90 /

-1.03 (-2.65%)

FB Facebook; also tag MVRS
$341.51 /

+0.56 (+0.16%)

EFX Equifax
$260.66 /

-9.1 (-3.37%)

DWAC Digital World Acquisition
$25.69 /

+15.73 (+157.93%)

DIDI Didi
$9.56 /

+0.95 (+11.03%)

DENN Denny's
$15.46 /

+0.86 (+5.89%)

CROX Crocs
$145.75 /

+9.47 (+6.95%)

CG Carlyle Group
$54.71 /

+1.21 (+2.26%)

BNTX BioNTech
$284.51 /

+14.82 (+5.50%)

AN AutoNation
$124.42 /

+7.3 (+6.23%)

AMZN Amazon.com
$3,427.51 /

+15.19 (+0.45%)

TSLA Tesla
$891.70 /

+26.72 (+3.09%)

10/21/21 RBC Capital
Tesla price target raised to $800 from $755 at RBC Capital
10/21/21 Credit Suisse
Tesla price target raised to $830 from $800 at Credit Suisse
10/21/21 Wedbush
Tesla price target raised to $1,100 from $1,000 at Wedbush
10/21/21 Roth Capital
Tesla price target raised to $250 from $150 at Roth Capital
T AT&T
$25.71 /

-0.19 (-0.73%)

10/19/21 Citi
AT&T price target lowered to $30 from $32 at Citi
10/14/21
Fly Intel: Top five analyst upgrades
10/14/21 KeyBanc
AT&T upgraded to Sector Weight from Underweight at KeyBanc
10/14/21 KeyBanc
AT&T upgraded to Sector Weight from Underweight at KeyBanc
IBM IBM
$130.07 /

-11.72 (-8.27%)

10/21/21 Morgan Stanley
IBM's Q3 'a pause on the path to improving growth,' says Morgan Stanley
10/06/21 Evercore ISI
IBM removed from Tactical Outperform list at Evercore ISI
10/05/21 Credit Suisse
IBM price target raised to $176 from $167 at Credit Suisse
10/01/21
Fly Intel: Top five analyst initiations
PFE Pfizer
$42.62 /

-0.17 (-0.40%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$284.51 /

+14.82 (+5.50%)

10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
DWAC Digital World Acquisition
$25.69 /

+15.73 (+157.93%)

DIDI Didi
$9.56 /

+0.95 (+11.03%)

07/28/21 Alliance Global Partners
Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
07/28/21 Alliance Global Partners
iClick Interactive price target lowered to $15 from $21 at Alliance Global
07/26/21 Atlantic Equities
Atlantic Equities downgrades DiDi to Neutral amid active investigations
07/26/21 Atlantic Equities
DiDi downgraded to Neutral from Overweight at Atlantic Equities
AMZN Amazon.com
$3,427.51 /

+15.19 (+0.45%)

10/21/21 Oppenheimer
Activision Blizzard price target lowered to $100 from $105 at Oppenheimer
10/20/21 Bernstein
Amazon.com may be more sheltered from broader sector declines, says Bernstein
10/13/21 Baird
Amazon.com weakness would be a buying opportunity, says Baird
10/12/21 JPMorgan
JPMorgan says Alphabet 'clearly the most liked' mega-cap internet stock
MU Micron
$67.90 /

-0.39 (-0.57%)

10/19/21 Mizuho
Micron downgraded to Neutral from Buy at Mizuho
10/15/21 BofA
Micron reinstated with a Neutral at BofA
10/15/21 BofA
Micron reinstated with a Neutral at BofA
10/14/21 Goldman Sachs
Micron price target lowered to $88 from $104 at Goldman Sachs
FB Facebook; also tag MVRS
$341.51 /

+0.56 (+0.16%)

10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/18/21 Credit Suisse
Facebook algorithm, service outages grab investor attention, says Credit Suisse
10/15/21 Evercore ISI
Facebook added to 'Tactical Underperform List' at Evercore ISI
10/13/21 Tigress Financial
Facebook price target raised to $466 from $430 at Tigress Financial
CG Carlyle Group
$54.71 /

+1.21 (+2.26%)

09/13/21
Fly Intel: Top five analyst upgrades
09/13/21 BMO Capital
Carlyle Group upgraded to Outperform from Market Perform at BMO Capital
08/11/21 Deutsche Bank
Carlyle Group upgraded to Buy on durable earnings power at Deutsche Bank
08/11/21 Deutsche Bank
Carlyle Group upgraded to Buy from Hold at Deutsche Bank
TSC TriState Capital
$30.22 /

+7.49 (+32.95%)

07/23/21 B. Riley
TriState Capital price target raised to $28 from $26 at B. Riley
07/12/21 B. Riley
TriState Capital upgraded to Buy on share pullback at B. Riley
07/12/21 B. Riley
TriState Capital upgraded to Buy from Neutral at B. Riley
04/26/21 B. Riley
TriState Capital price target raised to $26 from $21 at B. Riley
RJF Raymond James
$98.68 /

-2.76 (-2.72%)

10/21/21 JMP Securities
Raymond James price target raised to $112 from $103 at JMP Securities
10/11/21 Citi
Raymond James added to U.S. Focus List at Citi
09/17/21 Citi
Citi ups Raymond James target, opens 'Positive Catalyst Watch'
08/03/21 Citi
Raymond James price target lowered to $205 from $215 at Citi
KDMN Kadmon
$9.39 /

+0.81 (+9.45%)

09/14/21 Mizuho
Kadmon downgraded to Neutral from Buy at Mizuho
09/10/21 UBS
Kadmon downgraded to Neutral from Buy at UBS
09/09/21 Jefferies
Kadmon downgraded to Hold from Buy at Jefferies
09/09/21 Benchmark
Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
SNY Sanofi
$49.07 /

-0.06 (-0.12%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
SKLZ Skillz
$9.96 /

+0.79 (+8.62%)

08/04/21 Canaccord
Skillz price target lowered to $23 from $30 at Canaccord
08/04/21 Wedbush
Skillz price target lowered to $25 from $34 at Wedbush
07/28/21
Fly Intel: Top five analyst initiations
07/28/21 RBC Capital
Skillz initiated with a Sector Perform at RBC Capital
VALE Vale
$13.06 /

-0.785 (-5.67%)

10/21/21 RBC Capital
Vale double-downgraded to Underperform from Outperform at RBC Capital
10/21/21 RBC Capital
Vale downgraded to Underperform from Outperform at RBC Capital
10/20/21 Jefferies
Jefferies downgrades trio of iron ore miners on near-term downside risk
10/20/21 Jefferies
Vale downgraded to Hold from Buy at Jefferies
SHPW Shapeways
$9.07 /

-1.77 (-16.33%)

07/28/21 Lake Street
Galileo Acquisition Corp. initiated with a Buy at Lake Street
AN AutoNation
$124.42 /

+7.3 (+6.23%)

09/28/21 Morgan Stanley
AutoNation upgraded to Equal Weight from Underweight at Morgan Stanley
07/20/21 Truist
AutoNation price target raised to $110 from $100 at Truist
07/16/21 BofA
AutoNation price target raised to $171 from $161 at BofA
04/22/21
Fly Intel: Top five analyst upgrades
CROX Crocs
$145.75 /

+9.47 (+6.95%)

10/21/21 Piper Sandler
Crocs price target raised to $215 from $212 at Piper Sandler
10/19/21 Baird
Crocs remains an underappreciated story with positive setup, says Baird
10/08/21 Piper Sandler
Crocs pullback an opportunity to own best-in-class story, says Piper Sandler
10/05/21 Piper Sandler
Piper teen survey shows clothing outranked food for first time since 2014
EFX Equifax
$260.66 /

-9.1 (-3.37%)

10/14/21 Evercore ISI
Equifax resumed with an Outperform at Evercore ISI
10/14/21 Needham
Equifax price target raised to $295 from $288 at Needham
08/17/21 Barclays
Equifax price target raised to $330 from $285 at Barclays
07/28/21 Barclays
Equifax price target raised to $285 from $270 at Barclays
FCX Freeport McMoRan
$37.90 /

-1.03 (-2.65%)

10/06/21 Exane BNP Paribas
Freeport McMoRan upgraded to Outperform from Neutral at Exane BNP Paribas
09/29/21 BofA
Freeport McMoRan reinstated with a Buy at BofA
09/28/21 Morgan Stanley
Freeport McMoRan price target lowered to $32 from $37 at Morgan Stanley
09/16/21 Deutsche Bank
Freeport McMoRan price target lowered to $46 from $47 at Deutsche Bank
UNP Union Pacific
$228.45 /

+0.46 (+0.20%)

10/08/21
Fly Intel: Top five analyst upgrades
10/08/21 JPMorgan
Union Pacific upgraded to Overweight on recent selloff at JPMorgan
10/08/21 JPMorgan
Union Pacific upgraded to Overweight from Neutral at JPMorgan
10/04/21
Fly Intel: Top five analyst upgrades
LPSN LivePerson
$52.30 /

-4.84 (-8.47%)

10/21/21
Fly Intel: Top five analyst downgrades
10/21/21 Barclays
LivePerson downgraded to Underweight from Overweight at Barclays
09/17/21 Barclays
LivePerson price target raised to $80 from $76 at Barclays
07/01/21
Fly Intel: Top five analyst initiations
PLD Prologis
$144.21 /

+0.79 (+0.55%)

10/21/21
Fly Intel: Top five analyst upgrades
10/21/21 Goldman Sachs
Prologis upgraded to Conviction Buy from Buy at Goldman Sachs
10/20/21 BTIG
Prologis price target raised to $161 from $146 at BTIG
10/19/21 Barclays
Prologis price target raised to $161 from $159 at Barclays
DENN Denny's
$15.46 /

+0.86 (+5.89%)

10/21/21 Truist
Denny's upgraded to Buy from Hold at Truist
10/20/21 Truist
Denny's upgraded to Buy from Hold at Truist
10/08/21
Fly Intel: Top five analyst initiations
10/08/21 Deutsche Bank
Denny's initiated with Hold, $17 target at Deutsche Bank
TCRR TCR2 Therapeutics
$6.88 /

-0.295 (-4.11%)

10/21/21 BMO Capital
TCR2 Therapeutics price target lowered to $38 from $44 at BMO Capital
10/21/21 Mizuho
TCR2 Therapeutics price target lowered to $20 from $51 at Mizuho
10/21/21 SVB Leerink
SVB Leerink downgrades TCR2 on 'protracted road' to recovery
10/20/21 SVB Leerink
TCR2 Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
MTCH Match Group
$165.86 /

+6.79 (+4.27%)

10/12/21 Jefferies
Jefferies positive on Q3 set-up for Match Group and Bumble
08/05/21 Morgan Stanley
Morgan Stanley buyers of Match Group on post-earnings pullback
07/21/21 Truist
Match Group price target raised to $190 from $160 at Truist
07/09/21
Fly Intel: Top five analyst initiations
GOOGL Alphabet Class A
$2,823.70 /

-11.32 (-0.40%)

10/21/21 Stephens
Roku sits in 'more enviable' position in fight over YouTube TV, says Stephens
10/21/21 Mizuho
Alphabet price target raised to $3,100 from $3,000 at Mizuho
10/20/21 Barclays
Zoom Video initiated with an Equal Weight at Barclays
GOOG Alphabet
$2,844.15 /

-1.85 (-0.07%)

VALE Vale
$13.06 /

-0.785 (-5.67%)

UNP Union Pacific
$228.45 /

+0.46 (+0.20%)

TSLA Tesla
$891.70 /

+26.72 (+3.09%)

TSC TriState Capital
$30.22 /

+7.49 (+32.95%)

TCRR TCR2 Therapeutics
$6.88 /

-0.295 (-4.11%)

T AT&T
$25.71 /

-0.19 (-0.73%)

SNY Sanofi
$49.07 /

-0.06 (-0.12%)

SKLZ Skillz
$9.96 /

+0.79 (+8.62%)

RJF Raymond James
$98.68 /

-2.76 (-2.72%)

PLD Prologis
$144.21 /

+0.79 (+0.55%)

PFE Pfizer
$42.62 /

-0.17 (-0.40%)

MU Micron
$67.90 /

-0.39 (-0.57%)

MTCH Match Group
$165.86 /

+6.79 (+4.27%)

LPSN LivePerson
$52.30 /

-4.84 (-8.47%)

IBM IBM
$130.07 /

-11.72 (-8.27%)

GOOGL Alphabet Class A
$2,823.70 /

-11.32 (-0.40%)

FCX Freeport McMoRan
$37.90 /

-1.03 (-2.65%)

FB Facebook; also tag MVRS
$341.51 /

+0.56 (+0.16%)

EFX Equifax
$260.66 /

-9.1 (-3.37%)

DENN Denny's
$15.46 /

+0.86 (+5.89%)

CROX Crocs
$145.75 /

+9.47 (+6.95%)

CG Carlyle Group
$54.71 /

+1.21 (+2.26%)

BNTX BioNTech
$284.51 /

+14.82 (+5.50%)

AN AutoNation
$124.42 /

+7.3 (+6.23%)

AMZN Amazon.com
$3,427.51 /

+15.19 (+0.45%)

  • 30
    Jun
  • 19
    May
  • 19
    Mar
  • 12
    Mar
  • 20
    Jan
VALE Vale
$13.06 /

-0.785 (-5.67%)

UNP Union Pacific
$228.45 /

+0.46 (+0.20%)

TSLA Tesla
$891.70 /

+26.72 (+3.09%)

T AT&T
$25.71 /

-0.19 (-0.73%)

SNY Sanofi
$49.07 /

-0.06 (-0.12%)

SKLZ Skillz
$9.96 /

+0.79 (+8.62%)

RJF Raymond James
$98.68 /

-2.76 (-2.72%)

PFE Pfizer
$42.62 /

-0.17 (-0.40%)

MU Micron
$67.90 /

-0.39 (-0.57%)

MTCH Match Group
$165.86 /

+6.79 (+4.27%)

IBM IBM
$130.07 /

-11.72 (-8.27%)

GOOGL Alphabet Class A
$2,823.70 /

-11.32 (-0.40%)

FCX Freeport McMoRan
$37.90 /

-1.03 (-2.65%)

FB Facebook; also tag MVRS
$341.51 /

+0.56 (+0.16%)

EFX Equifax
$260.66 /

-9.1 (-3.37%)

DIDI Didi
$9.56 /

+0.95 (+11.03%)

DENN Denny's
$15.46 /

+0.86 (+5.89%)

CROX Crocs
$145.75 /

+9.47 (+6.95%)

CG Carlyle Group
$54.71 /

+1.21 (+2.26%)

BNTX BioNTech
$284.51 /

+14.82 (+5.50%)

AMZN Amazon.com
$3,427.51 /

+15.19 (+0.45%)

UNP Union Pacific
$228.45 /

+0.46 (+0.20%)

TSLA Tesla
$891.70 /

+26.72 (+3.09%)

TCRR TCR2 Therapeutics
$6.88 /

-0.295 (-4.11%)

T AT&T
$25.71 /

-0.19 (-0.73%)

SNY Sanofi
$49.07 /

-0.06 (-0.12%)

SKLZ Skillz
$9.96 /

+0.79 (+8.62%)

SHPW Shapeways
$9.07 /

-1.77 (-16.33%)

PLD Prologis
$144.21 /

+0.79 (+0.55%)

PFE Pfizer
$42.62 /

-0.17 (-0.40%)

MU Micron
$67.90 /

-0.39 (-0.57%)

MTCH Match Group
$165.86 /

+6.79 (+4.27%)

KDMN Kadmon
$9.39 /

+0.81 (+9.45%)

IBM IBM
$130.07 /

-11.72 (-8.27%)

GOOGL Alphabet Class A
$2,823.70 /

-11.32 (-0.40%)

FCX Freeport McMoRan
$37.90 /

-1.03 (-2.65%)

FB Facebook; also tag MVRS
$341.51 /

+0.56 (+0.16%)

EFX Equifax
$260.66 /

-9.1 (-3.37%)

DWAC Digital World Acquisition
$25.69 /

+15.73 (+157.93%)

DIDI Didi
$9.56 /

+0.95 (+11.03%)

CROX Crocs
$145.75 /

+9.47 (+6.95%)

CG Carlyle Group
$54.71 /

+1.21 (+2.26%)

BNTX BioNTech
$284.51 /

+14.82 (+5.50%)

AN AutoNation
$124.42 /

+7.3 (+6.23%)

AMZN Amazon.com
$3,427.51 /

+15.19 (+0.45%)

VALE Vale
$13.06 /

-0.785 (-5.67%)

UNP Union Pacific
$228.45 /

+0.46 (+0.20%)

TSLA Tesla
$891.70 /

+26.72 (+3.09%)

T AT&T
$25.71 /

-0.19 (-0.73%)

SKLZ Skillz
$9.96 /

+0.79 (+8.62%)

SHPW Shapeways
$9.07 /

-1.77 (-16.33%)

PFE Pfizer
$42.62 /

-0.17 (-0.40%)

MU Micron
$67.90 /

-0.39 (-0.57%)

MTCH Match Group
$165.86 /

+6.79 (+4.27%)

KDMN Kadmon
$9.39 /

+0.81 (+9.45%)

IBM IBM
$130.07 /

-11.72 (-8.27%)

GOOGL Alphabet Class A
$2,823.70 /

-11.32 (-0.40%)

FCX Freeport McMoRan
$37.90 /

-1.03 (-2.65%)

FB Facebook; also tag MVRS
$341.51 /

+0.56 (+0.16%)

EFX Equifax
$260.66 /

-9.1 (-3.37%)

DIDI Didi
$9.56 /

+0.95 (+11.03%)

CROX Crocs
$145.75 /

+9.47 (+6.95%)

AMZN Amazon.com
$3,427.51 /

+15.19 (+0.45%)

Recommendations
Raymond James price target raised to $112 from $103 at JMP Securities » 06:17
10/21/21
10/21
06:17
10/21/21
06:17
RJF

Raymond James

$101.65 /

+1.49 (+1.49%)

JMP Securities analyst…

JMP Securities analyst Devin Ryan raised the firm's price target on Raymond James to $112 from $103 and keeps an Outperform rating on the shares. The analyst cites the company's greater earnings power after its announced acquisition of TriState Capital.

ShowHide Related Items >><<
RJF Raymond James
$101.65 /

+1.49 (+1.49%)

RJF Raymond James
$101.65 /

+1.49 (+1.49%)

10/11/21 Citi
Raymond James added to U.S. Focus List at Citi
09/17/21 Citi
Citi ups Raymond James target, opens 'Positive Catalyst Watch'
08/03/21 Citi
Raymond James price target lowered to $205 from $215 at Citi
07/21/21 Jefferies
Raymond James initiated with a Buy at Jefferies
RJF Raymond James
$101.65 /

+1.49 (+1.49%)

RJF Raymond James
$101.65 /

+1.49 (+1.49%)

Hot Stocks
Raymond James to acquire TriState Capital for $1.1B in cash, stock » 17:34
10/20/21
10/20
17:34
10/20/21
17:34
RJF

Raymond James

$101.65 /

+1.49 (+1.49%)

, TSC

TriState Capital

$22.75 /

+0.95 (+4.36%)

Raymond James Financial…

Raymond James Financial (RJF) and TriState Capital Holdings (TSC) have entered into a definitive agreement under which Raymond James will acquire TriState Capital in a combination cash and stock transaction, valued at approximately $1.1B. Under the terms of the agreement, TriState Capital common stockholders will receive $6.00 cash and 0.25 Raymond James shares for each share of TriState Capital common stock, which represents per share consideration of $31.09 based on the closing price of Raymond James common stock on October 19, 2021. Raymond James has entered into an agreement with the sole holder of the TriState Capital Series C Perpetual Non-Cumulative Convertible Non-Voting Preferred Stock pursuant to which the Series C Convertible Preferred will be converted to common shares at the prescribed exchange ratio and cashed out at $30 per share. The TriState Capital Series A Non-Cumulative Perpetual Preferred Stock and Series B Non-Cumulative Perpetual Preferred Stock will remain outstanding and be converted into equivalent Preferred Stock of Raymond James. TriState Capital will continue operating as a separately branded firm and as a stand-alone division and independently chartered bank subsidiary of Raymond James, with Jim Getz remaining Chairman, Brian Fetterolf remaining TriState Capital Bank's CEO and Tim Riddle remaining Chartwell's CEO. Management and approximately 350 associates are expected to remain with the firm in its existing office locations to support TriState Capital's continued growth and high service levels. The deal is projected to be accretive to diluted earnings per share in the first full year post closing (excluding acquisition-related expenses), with over 8% accretion in diluted earnings per share after the third year; accretion estimates increase meaningfully, by approximately 400 basis points, assuming share repurchases post-closing to offset shares issued as part of the transaction consideration. Primary driver of cost synergies is replacing a portion of TriState Capital Bank's current and future higher-cost deposits with Raymond James' lower-cost deposits from the Raymond James Bank Deposit Program. The acquisition is subject to customary closing conditions, including regulatory approvals and approval by TriState Capital shareholders, and is expected to close in 2022.

ShowHide Related Items >><<
RJF Raymond James
$101.65 /

+1.49 (+1.49%)

RJF Raymond James
$101.65 /

+1.49 (+1.49%)

10/11/21 Citi
Raymond James added to U.S. Focus List at Citi
09/17/21 Citi
Citi ups Raymond James target, opens 'Positive Catalyst Watch'
08/03/21 Citi
Raymond James price target lowered to $205 from $215 at Citi
07/21/21 Jefferies
Raymond James initiated with a Buy at Jefferies
TSC TriState Capital
$22.75 /

+0.95 (+4.36%)

07/23/21 B. Riley
TriState Capital price target raised to $28 from $26 at B. Riley
07/12/21 B. Riley
TriState Capital upgraded to Buy on share pullback at B. Riley
07/12/21 B. Riley
TriState Capital upgraded to Buy from Neutral at B. Riley
04/26/21 B. Riley
TriState Capital price target raised to $26 from $21 at B. Riley
TSC TriState Capital
$22.75 /

+0.95 (+4.36%)

RJF Raymond James
$101.65 /

+1.49 (+1.49%)

RJF Raymond James
$101.65 /

+1.49 (+1.49%)

Recommendations
Raymond James added to U.S. Focus List at Citi » 06:03
10/11/21
10/11
06:03
10/11/21
06:03
RJF

Raymond James

/

+

Citi analyst William Katz…

Citi analyst William Katz raised the firm's price target on Raymond James to $147 from $143 and keeps a Buy rating on the shares. The analyst also added the shares to Citi's U.S. Focus List into the Q3 earnings season.

ShowHide Related Items >><<
RJF Raymond James
/

+

RJF Raymond James
/

+

09/17/21 Citi
Citi ups Raymond James target, opens 'Positive Catalyst Watch'
08/03/21 Citi
Raymond James price target lowered to $205 from $215 at Citi
07/21/21 Jefferies
Raymond James initiated with a Buy at Jefferies
07/15/21 Citi
Citi opens '30-Day Positive Catalyst Watch' on Raymond James
RJF Raymond James
/

+

RJF Raymond James
/

+

Recommendations
Citi ups Raymond James target, opens 'Positive Catalyst Watch' » 05:38
09/17/21
09/17
05:38
09/17/21
05:38
RJF

Raymond James

$134.47 /

-1.345 (-0.99%)

Citi analyst William Katz…

Citi analyst William Katz raised the firm's price target on Raymond James to $214 from $205 and keeps a Buy rating on the shares. The analyst also opened a new "90-Day Positive Catalyst Watch" on Raymond James. Katz believes consensus estimates "may be structurally too low," particularly on Capital Markets contribution, while noting his estimates continue to carry an above consensus expense outlook. He expects "material upward" consensus earnings revisions for Raymond James.

ShowHide Related Items >><<
RJF Raymond James
$134.47 /

-1.345 (-0.99%)

RJF Raymond James
$134.47 /

-1.345 (-0.99%)

08/03/21 Citi
Raymond James price target lowered to $205 from $215 at Citi
07/21/21 Jefferies
Raymond James initiated with a Buy at Jefferies
07/15/21 Citi
Citi opens '30-Day Positive Catalyst Watch' on Raymond James
07/12/21 Citi
Citi names Raymond James top broker deal pick, ups price target
RJF Raymond James
$134.47 /

-1.345 (-0.99%)

RJF Raymond James
$134.47 /

-1.345 (-0.99%)

Hot Stocks
Raymond James selects FactSet to provide market data for financial advisors » 08:42
09/08/21
09/08
08:42
09/08/21
08:42
RJF

Raymond James

$138.56 /

-0.5 (-0.36%)

, FDS

FactSet

$382.06 /

-4 (-1.04%)

FactSet (FDS) announced…

FactSet (FDS) announced that it has been selected by Raymond James (RJF) as its market data provider for financial advisors in Canada. FactSet is working with Raymond James Ltd. to implement its web-based Wealth Workstation to over 900 wealth management professionals. The virtual implementation will provide them with personalized and efficient access to comprehensive multi-asset class market data and analytics within a modern and easy-to-use platform. FactSet's Wealth Workstation will also integrate Raymond James Ltd.'s internal model portfolios and approved lists, strengthening financial advisors' collaboration with home office research and strategy teams. This integration will support productivity and efficiency by delivering tailored and actionable portfolio insights to enhance their client engagement efforts. Seamless web and mobile connectivity will allow for remote use to accommodate flexible working environments without compromising users' access.

ShowHide Related Items >><<
RJF Raymond James
$138.56 /

-0.5 (-0.36%)

FDS FactSet
$382.06 /

-4 (-1.04%)

RJF Raymond James
$138.56 /

-0.5 (-0.36%)

08/03/21 Citi
Raymond James price target lowered to $205 from $215 at Citi
07/21/21 Jefferies
Raymond James initiated with a Buy at Jefferies
07/15/21 Citi
Citi opens '30-Day Positive Catalyst Watch' on Raymond James
07/12/21 Citi
Citi names Raymond James top broker deal pick, ups price target
FDS FactSet
$382.06 /

-4 (-1.04%)

08/25/21
Fly Intel: Top five analyst upgrades
08/25/21 Barclays
FactSet upgraded to Overweight from Equal Weight at Barclays
07/07/21 RBC Capital
FactSet initiated with an Outperform at RBC Capital
06/30/21 Deutsche Bank
FactSet price target raised to $330 from $315 at Deutsche Bank
RJF Raymond James
$138.56 /

-0.5 (-0.36%)

FDS FactSet
$382.06 /

-4 (-1.04%)

RJF Raymond James
$138.56 /

-0.5 (-0.36%)

FDS FactSet
$382.06 /

-4 (-1.04%)

FDS FactSet
$382.06 /

-4 (-1.04%)

Over a quarter ago
Periodicals
Raymond James pushes back return-to-office date, Bloomberg reports » 06:22
09/01/21
09/01
06:22
09/01/21
06:22
RJF

Raymond James

$139.90 /

-0.67 (-0.48%)

Raymond James has moved…

Raymond James has moved its return-to-office date back to the middle of October as coronavirus ramps up in its home state of Florida, Bloomberg's Matthew Monks and Sonali Basak reports, citing people familiar with the matter. The company told employees they don't have to return to the office until October 11, after initially wanting some staff to return next week. Reference Link

ShowHide Related Items >><<
RJF Raymond James
$139.90 /

-0.67 (-0.48%)

RJF Raymond James
$139.90 /

-0.67 (-0.48%)

08/03/21 Citi
Raymond James price target lowered to $205 from $215 at Citi
07/21/21 Jefferies
Raymond James initiated with a Buy at Jefferies
07/15/21 Citi
Citi opens '30-Day Positive Catalyst Watch' on Raymond James
07/12/21 Citi
Citi names Raymond James top broker deal pick, ups price target
RJF Raymond James
$139.90 /

-0.67 (-0.48%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.